The potential benefits of epigenetic therapy research
Targeting apoptosis - developing drugs to inhibit Bcl-2 and Mcl-1
The IFM 2012-03 trial: what will the next step be?
Integrating cellular therapies into clinical practice
TGR-1202 in CLL and non-Hodgkin lymphoma